Effects of Siltuximab Versus Corticosteroids in Preventing COVID−19 Pneumonia Disease Progression: Multicentre, Open‐Label, Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Effects of Siltuximab Versus Corticosteroids in Preventing COVID−19 Pneumonia Disease Progression: Multicentre, Open‐Label, Randomized Clinical Trial.
Authors: Leal, Lorna1,2,3 (AUTHOR) lorna.leal@gmail.com, del Puerto Bernoy González, María1 (AUTHOR), Castán, Clara1 (AUTHOR), Meira, Fernanda1 (AUTHOR), Dueñas, Gerard1 (AUTHOR), Pich, Judit4 (AUTHOR), Hernández‐Meneses, Marta1 (AUTHOR), Rico, Verónica1 (AUTHOR), García‐Pouton, Nicole1 (AUTHOR), Agüero, Daiana1 (AUTHOR), de Lazzari, Elisa1 (AUTHOR), Tomé, Adrià5 (AUTHOR), Herrera, Sabina1 (AUTHOR), Muñóz, José3,6,7 (AUTHOR), Almuedo, Alex3,6,7 (AUTHOR), Prieto‐González, Sergio2,3,5,8 (AUTHOR), Castro, Pedro2,3,9 (AUTHOR), Marcos, Maria Angeles3,6,10 (AUTHOR), Tuset, Montse2,11 (AUTHOR), Paredes, Roger12 (AUTHOR)
Source: CTS: Clinical & Translational Science. Feb2026, Vol. 19 Issue 2, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17528054
DOI:10.1111/cts.70491